Engineering human endogenous retrovirus-K for improving immunogenicity and broad cancer targeting.

Müller MD, Neukirch L, Ragonnaud E, Bermejo AV, Daradoumis J, Jaded V, Engdal ES, Faas F, Perez-Penco M, Picon-Jara C, Nielsen KN, Duvnjak L, Boilesen DR, Kusiński S, Skandorff I, Skeltved N, Trinh LLN, Turner L, Grunddal KV, Darusman HS, Mariya S, Schrödel S, Rohrberg KS, Bagger FO, Thirion C, Straten PT, Andersson AC, Holst PJ

Open source

DOI: 10.1186/s12967-026-09012-1
Published: 2026 Sep 24
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-09012-1,
  title = {Engineering human endogenous retrovirus-K for improving immunogenicity and broad cancer targeting.},
  author = {Müller MD and Neukirch L and Ragonnaud E and Bermejo AV and Daradoumis J and Jaded V and Engdal ES and Faas F and Perez-Penco M and Picon-Jara C and Nielsen KN and Duvnjak L and Boilesen DR and Kusiński S and Skandorff I and Skeltved N and Trinh LLN and Turner L and Grunddal KV and Darusman HS and Mariya S and Schrödel S and Rohrberg KS and Bagger FO and Thirion C and Straten PT and Andersson AC and Holst PJ},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-09012-1},
  url = {https://doi.org/10.1186/s12967-026-09012-1}
}

RIS

TY  - JOUR
TI  - Engineering human endogenous retrovirus-K for improving immunogenicity and broad cancer targeting.
AU  - Müller MD
AU  - Neukirch L
AU  - Ragonnaud E
AU  - Bermejo AV
AU  - Daradoumis J
AU  - Jaded V
AU  - Engdal ES
AU  - Faas F
AU  - Perez-Penco M
AU  - Picon-Jara C
AU  - Nielsen KN
AU  - Duvnjak L
AU  - Boilesen DR
AU  - Kusiński S
AU  - Skandorff I
AU  - Skeltved N
AU  - Trinh LLN
AU  - Turner L
AU  - Grunddal KV
AU  - Darusman HS
AU  - Mariya S
AU  - Schrödel S
AU  - Rohrberg KS
AU  - Bagger FO
AU  - Thirion C
AU  - Straten PT
AU  - Andersson AC
AU  - Holst PJ
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-09012-1
UR  - https://doi.org/10.1186/s12967-026-09012-1
ER  -

APA

MD, M., L, N., E, R., AV, B., J, D., V, J., ES, E., F, F., M, P., C, P., KN, N., L, D., DR, B., S, K., I, S., N, S., LLN, T., L, T., KV, G., HS, D., S, M., S, S., KS, R., FO, B., C, T., PT, S., AC, A., & PJ, H. (2026). Engineering human endogenous retrovirus-K for improving immunogenicity and broad cancer targeting.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-09012-1

Source records

pubmed · retrieved 2026-11-10T19:00:21.352Z